Exodus Point Capital Management, LP Moon Lake Immunotherapeutics Transaction History
Exodus Point Capital Management, LP
- $11.4 Billion
- Q2 2025
A detailed history of Exodus Point Capital Management, LP transactions in Moon Lake Immunotherapeutics stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 25,313 shares of MLTX stock, worth $234,904. This represents 0.01% of its overall portfolio holdings.
Number of Shares
25,313Holding current value
$234,904% of portfolio
0.01%Shares
3 transactions
Others Institutions Holding MLTX
# of Institutions
158Shares Held
54.8MCall Options Held
799KPut Options Held
661K-
Bvf Inc San Francisco, CA19.8MShares$183 Million36.63% of portfolio
-
Cormorant Asset Management, LP Boston, MA8.49MShares$78.8 Million40.43% of portfolio
-
Avoro Capital Advisors LLC New York, NY4.15MShares$38.5 Million3.57% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.61MShares$24.3 Million0.01% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il1.67MShares$15.5 Million0.01% of portfolio
About MoonLake Immunotherapeutics
- Ticker MLTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,925,600
- Market Cap $343M
- Description
- MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It is developing Sonelokimab, a novel investigational Nanobody therapy for the treatment of inflammation. The company is involved in conducting Phase II trials for hidradenitis suppurativa, psoriatic arthritis, ankylosing spondylitis, or rad...